Product Information
EFAVIRENZ-EMTRICITABINE-TENOFOV DISOP FUM 600-200-300 MG TAB is a generic product labeled by Cipla USA Inc., priced at $1.1249 per EA under NDC 69097021002. Its NADAC has been published 283 times since May 5, 2021.
FDA first approved this application on Jun 3, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
EFAVIRENZ-EMTRICITABINE-TENOFOV DISOP FUM 600-200-300 MG TAB
efavirenz, emtricitabine and tenofovir disoproxil fumarateStrength
600; 200; 300 mg/1; mg/1; mg/1
Manufacturer
Cipla USA Inc.NDC
69097021002
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATEApproval Type
Generic (ANDA)
FDA Application
ANDA206894FDA Approved
6/3/2019
TE Code
AB
On Market Since
3/30/2021
Pharmacological Classes
Price Statistics
The NADAC for EFAVIRENZ-EMTRICITABINE-TENOFOV DISOP FUM 600-200-300 MG TAB has been published 283 times since May 5, 2021, and over the history we have for it it has declined 98.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.1249 per EA |
|---|---|
| All-time high | $75.3743 (May 12, 2021) |
| All-time low | $1.1249 (Sep 23, 2026) |
| 52-week high | $1.4461 |
| 52-week low | $1.1249 |
| Median price | $1.7007 |
| Average price | $3.6550 |
| Largest weekly change | -89.2% (May 19, 2021) |
| Weeks tracked | 283 |
| Tracking since | May 5, 2021 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the efavirenz, emtricitabine and tenofovir disoproxil fumarate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Cipla USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
efavirenz, emtricitabine and tenofovir disoproxil fumarate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of EFAVIRENZ-EMTRICITABINE-TENOFOV DISOP FUM 600-200-300 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for EFAVIRENZ-EMTRICITABINE-TENOFOV DISOP FUM 600-200-300 MG TAB, manufactured by Cipla USA Inc., is $1.1249 per EA (NDC 69097021002), effective Sep 30, 2026.
How has the price of EFAVIRENZ-EMTRICITABINE-TENOFOV DISOP FUM 600-200-300 MG TAB changed over time?
Over the history we have for it, the NADAC for EFAVIRENZ-EMTRICITABINE-TENOFOV DISOP FUM 600-200-300 MG TAB has declined 98.5%. It has been tracked across 283 weekly CMS publications since May 5, 2021.
What are the highest and lowest recorded NADAC prices for EFAVIRENZ-EMTRICITABINE-TENOFOV DISOP FUM 600-200-300 MG TAB?
Since May 5, 2021, the NADAC for EFAVIRENZ-EMTRICITABINE-TENOFOV DISOP FUM 600-200-300 MG TAB has ranged from a low of $1.1249 (Sep 23, 2026) to a high of $75.3743 (May 12, 2021), with a median of $1.7007 per EA.
Are there cheaper alternatives to EFAVIRENZ-EMTRICITABINE-TENOFOV DISOP FUM 600-200-300 MG TAB?
No other NADAC-published product currently shares the active ingredient and strength of EFAVIRENZ-EMTRICITABINE-TENOFOV DISOP FUM 600-200-300 MG TAB in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures EFAVIRENZ-EMTRICITABINE-TENOFOV DISOP FUM 600-200-300 MG TAB?
EFAVIRENZ-EMTRICITABINE-TENOFOV DISOP FUM 600-200-300 MG TAB (NDC 69097021002) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.